Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant

Title
Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant
Authors
Keywords
-
Journal
npj Vaccines
Volume 5, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-23
DOI
10.1038/s41541-020-00211-5

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started